171 related articles for article (PubMed ID: 16259219)
1. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
Haluzik M
Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin, obesity, and cardiovascular disease.
Fasshauer M; Paschke R; Stumvoll M
Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
[TBL] [Abstract][Full Text] [Related]
3. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
5. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
[TBL] [Abstract][Full Text] [Related]
6. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
[TBL] [Abstract][Full Text] [Related]
7. [Research advancement of adipocytokine adiponectin].
Xiao FY; Lu FE
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):309-13. PubMed ID: 14992011
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin, obesity and atherosclerosis.
Behre CJ
Scand J Clin Lab Invest; 2007; 67(5):449-58. PubMed ID: 17763181
[TBL] [Abstract][Full Text] [Related]
10. The role of resistin in obesity-induced insulin resistance.
Haluzik M; Haluzikova D
Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
[TBL] [Abstract][Full Text] [Related]
12. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
Achari AE; Jain SK
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
15. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity].
Bastarrachea RA; Montero JC; Saavedra-Gajardo I; Cerda-Flores R; Machado-Domínguez A; Comuzzie AG
Rev Med Chil; 2008 Jan; 136(1):107-17. PubMed ID: 18483661
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin in health and disease.
Oh DK; Ciaraldi T; Henry RR
Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
[TBL] [Abstract][Full Text] [Related]
19. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
